1187364-41-5

Basic information

• Product Name: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid homoveratrylamine salt
• Synonyms: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid homoveratrylamine salt
• CAS NO: 1187364-41-5
• Molecular Weight: 767.429
• Mol File: 1187364-41-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid homoveratrylamine salt(CAS DataBase Reference)
• NIST Chemistry Reference: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid homoveratrylamine salt(1187364-41-5)
• EPA Substance Registry System: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid homoveratrylamine salt(1187364-41-5)

Safety Data

• Hazardous Substances Data: 1187364-41-5(Hazardous Substances Data)

Upstream product

• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 807638-71-7 2-[2-[3(S)-[3-[(1E)-2-(7-chloroquinoline-2-yl)ethenyl]phenyl]-3-methanesulfonyloxypropyl]phenyl]-2-propanol 
• 162515-68-6 1-(sulfanylmethyl)cyclopropaneacetic acid 
• 1228272-68-1 1-((mercaptomethyl)cyclopropyl)acetic acid homoveratrylamine salt 

Downstream Products

• 151767-02-1 Montelukast sodium 

Relevant articles and documents

NOVEL INTERMEDIATES FOR PRODUCING [R-(E)]-1-[[[1-[3-[2-(7- CHLORO -QUINOLINYL)ETHENYL]PHENYL]-3-[2-(1-HYDROXY- METHYLETHYL) PHENYL]PROPYL]THIO] METHYL] CYCLOPROPANEACETIC ACID, MONOSODIUM SALT AND PROCESS THEREOF

Disclosed herein are novel intermediates for producing [R-(E)]-1-[[[1-[3-[2-(7- chloro-2-quinolinyl)ethenyl]phenyl] -3 - [2-(1-hydroxy- 1 -methylethyl) phenyl] propyl]thio] methyl] cyclopropaneacetic acid, monosodium salt (montelukast sodium). Further the invention provides processes for preparing said intermediates.